Currently Viewing:
Currently Reading
PCT Just as Effective as MASCC for Predicting Serious Complications in Febrile Neutropenia
January 18, 2019 – Jaime Rosenberg
CMS Expands VBID in Medicare Advantage, Increases Risk Sharing in Part D
January 18, 2019 – Allison Inserro
Tracking Medicaid Expansion
January 18, 2019 – AJMC Staff
This Week in Managed Care: January 18, 2019
January 18, 2019
USPSTF Releases Draft Recommendation on Drugs to Lower Risk of Breast Cancer
January 18, 2019 – Samantha DiGrande
CMS Proposes Changes to ACA Premiums, Reducing Tax Credits
January 18, 2019 – Allison Inserro
5 Findings From the January 2019 Health IT Issue of AJMC®
January 18, 2019 – Christina Mattina
AJMC® in the Press, January 18, 2019
January 18, 2019 – AJMC Staff
What We're Reading: Price Hikes for Older Drugs; FDA Shifts Resources; Opioids and Birth Defects
January 18, 2019 – AJMC Staff

What We're Reading: Prescription Heroin; Healthcare Merger Scrutiny; Health of Migrants

AJMC Staff
Think tank RAND is suggesting that long-time heroin users who have failed on other treatments might be treated with pharmaceutical-grade heroin; House Democrats want more scrutiny on healthcare mergers as consolidation continues to lead to rising prices; a new study has found that migrants tend to be healthier and live longer than residents of the wealthy countries that they are traveling to.

Treatment With Pharmaceutical-Grade Heroin

With opioid-related deaths rising and a surge in illicit drugs being used, think tank RAND is suggesting something controversial: treating long-time heroin users with pharmaceutical-grade heroin. According to NPR, this controversial treatment is already happening in European countries and Canada as a way to provide a legal source of heroin to people who might get a tainted drug on the street. Heroin-assisted treatment would only be available to heroin users who have tried other treatments and have not had success. Research has shown patients treated with prescription heroin were more likely to stay in treatment and may even reduce criminal activity and improve patients’ physical and mental health.


House Democrats to Look Into Healthcare Mergers

Consolidation in healthcare has been associated with rising healthcare costs without a corresponding increase in quality of care, and House Democrats want more scrutiny on these mergers. The incoming chairs of the House Judiciary and its antitrust subcommittee have said healthcare mergers and monopoly power in healthcare markets are among their top concerns for 2019, according to The Washington Post. There has been a spate of megamergers recently, with the latest being CVS Health and Aetna. However, while that merger seemed to be a done deal, the US district court judge in Washington, DC, is considering delaying the merger until he has a chance to review it, reported The Hill. The Department of Justice had already approved the merger, but the judge ordered a hearing for December 18.


Migrants Are Healthier Than Residents of Countries They Travel To

A new study has found that migrants tend to be healthier and live longer than residents of the wealthy countries that they are traveling to, contrary to populist arguments that migrants pose a health risk. In addition, migrants are beneficial to the health system because they often become healthcare workers, reported Reuters. The study found that migrants were less likely to die of illnesses, and while they were more prone to infectious diseases, such as hepatitis and HIV, the diseases tended to spread among immigrant communities and not among the general population.

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!